Back to Search
Start Over
The potential for Treg-enhancing therapies in tissue, in particular skeletal muscle, regeneration.
- Source :
-
Clinical and experimental immunology [Clin Exp Immunol] 2023 Mar 16; Vol. 211 (2), pp. 138-148. - Publication Year :
- 2023
-
Abstract
- Foxp3+CD4+ regulatory T cells (Tregs) are famous for their role in maintaining immunological tolerance. With their distinct transcriptomes, growth-factor dependencies and T-cell receptor (TCR) repertoires, Tregs in nonlymphoid tissues, termed "tissue-Tregs," also perform a variety of functions to help assure tissue homeostasis. For example, they are important for tissue repair and regeneration after various types of injury, both acute and chronic. They exert this influence by controlling both the inflammatory tenor and the dynamics of the parenchymal progenitor-cell pool in injured tissues, thereby promoting efficient repair and limiting fibrosis. Thus, tissue-Tregs are seemingly attractive targets for immunotherapy in the context of tissue regeneration, offering several advantages over existing therapies. Using skeletal muscle as a model system, we discuss the existing literature on Tregs' role in tissue regeneration in acute and chronic injuries, and various approaches for their therapeutic modulation in such contexts, including exercise as a natural Treg modulator.<br /> (© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Immunology.)
- Subjects :
- Immune Tolerance
T-Lymphocytes, Regulatory
Muscle, Skeletal
Subjects
Details
- Language :
- English
- ISSN :
- 1365-2249
- Volume :
- 211
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Clinical and experimental immunology
- Publication Type :
- Academic Journal
- Accession number :
- 35972909
- Full Text :
- https://doi.org/10.1093/cei/uxac076